GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

KYNB · Jun 30, 2026

KYNTRA BIO, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001193125-26-349183General Corporate
Capex intensity9thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.00% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-209.35% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure0thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

-229.58% · OPTIONAL · VALID

Operating margin100thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.operating_margin

1192.27% · CORE · VALID

SBC intensity0thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

-66.76% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building
Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/8 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20264/5 normalizedLevel 3
Period transition

What moved in the state?

Growth Decreased
Previous
36.47%
Current
-209.35%
Delta
-245.82%
Inventory Pressure Decreased
Previous
90.53%
Current
-229.58%
Delta
-320.11%
Profitability Increased
Previous
-369.66%
Current
1192.27%
Delta
1561.93%
Sbc Intensity Decreased
Previous
30.79%
Current
-66.76%
Delta
-97.55%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Compared To · Pharmaceutical Preparations peers →Transitioned To · KYNB Fundamental State →Transitioned To · KYNB GROWTH_DECREASED →Transitioned To · KYNB INVENTORY_PRESSURE_DECREASED →Transitioned To · KYNB PROFITABILITY_INCREASED →Transitioned To · KYNB SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.